1. United States Renal Data System (USRDS). Incidence, prevalence, patient characteristics, and treatment modalities. In 2015 USRDS annual data report: epidemiology of kidney disease in the United States. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2015.
http://www.usrds.org/2015/view/v2_01.aspx
. Accessed 26 Jan 2016.
2. United States Renal Data System (USRDS). Medicare expenditures for persons with ESRD. In 2015 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2015.
http://www.usrds.org/2015/view/v2_11.aspx
. Accessed 26 Jan 2016.
3. National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-KDOQI). Clinical practice guidelines. 2015.
https://www.kidney.org/professionals/guidelines
. Accessed 26 Jan 2015.
4. Schon D, Blume SW, Niebauer K, et al. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers. Clin J Am Soc Nephrol. 2007;2:268–76.
5. Miller PE, Tolwani A, Luscy CP, et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int. 1999;56:275–80.